We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Guidance for living safely with respiratory infections, including coronavirus (COVID-19).
How to use a multiphase optimisation strategy (MOST) to evaluate your digital health product.
UK Statements delivered on 22 and 23 May 2024 at the WTO General Council in Geneva.
How to use a cost utility analysis to evaluate your digital health product.
Working with others to embed the importance of place within the published guidance.
Guidance documents and updates for Sellafield Ltd employees.
This guidance provides information on COVID-19 in homelessness, domestic abuse refuge, respite room and asylum seeker accommodation settings.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
Information for patients, healthcare professionals and developers of new medicines
This playbook explains how we use social media at GDS. In it, we share our best practice, what we've learned and what we're planning to do.
A resource to help local commissioners provide cost-effective interventions for children aged up to 5 and pregnant women.
How to use feedback from marketplace reviews to evaluate your digital health product.
Guidance on choosing evaluation study types and methods.
This collection brings together reviews of best practice and opportunities for improvement in government financial reporting.
Past and current clinical trials into therapeutic and antiviral treatments for COVID-19, how to take part, and which treatments have proven to be effective.
Lassa virus causes Lassa fever, an acute viral haemorrhagic fever (VHF).
Preventing people in England from developing high blood pressure (hypertension), and detecting and managing it better in those who have it.
The Charity Commission offers advice to all charities as it closes its case into the Actors’ Benevolent Fund.
How to write up and share your findings
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).